NCT04166032View on ClinicalTrials.gov

Validation Study for the Alertgy Non-invasive Continuous Glucose Monitor (ANICGM)

CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

November 6, 2019

Primary Completion Date

February 4, 2020

Study Completion Date

May 30, 2020

Conditions
Type 2 Diabetes
Interventions
DEVICE

Alertgy non-invasive continuous glucose monitoring device (ANICGM)

Alertgy non-invasive continuous glucose monitoring device (ANICGM)

Trial Locations (1)

44195

Cleveland Clinic, Cleveland

All Listed Sponsors
collaborator

Alertgy

INDUSTRY

lead

The Cleveland Clinic

OTHER

NCT04166032 - Validation Study for the Alertgy Non-invasive Continuous Glucose Monitor (ANICGM) | Biotech Hunter | Biotech Hunter